MetaADEDB 2.0 @ LMMD
Methylprednisolone Acetate
(PLBHSZGDDKCEHR-LFYFAGGJSA-N)
Structure
SMILES
CC(=O)OCC(=O)[C@@]1(O)CC[C@@H]2[C@]1(C)C[C@H](O)[C@H]1[C@H]2C[C@@H](C2=CC(=O)C=C[C@]12C)C
Molecular Formula:
C24H32O6
Molecular Weight:
416.507
Log P:
2.3744
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
2
TPSA:
100.9
CAS Number(s):
53-36-1
Synonym(s)
1.
Methylprednisolone Acetate
2.
Acetyl-Methylprednisolone
3.
Depo-Medrol
4.
Depo-Medrone
5.
Methylprednisolone Acetate, (11beta,16alpha)-isomer
6.
Methylprednisolone Acetate, (11beta,16beta)-isomer
7.
Methylprednisolone-21-acetate
8.
Acetyl Methylprednisolone
9.
Depo Medrol
10.
Depo Medrone
11.
Methylprednisolone 21 acetate
External Link(s)
MeSHD000077555
PubChem Compound5877
BindingDB233194
ChEBI6889
CHEMBLCHEMBL1364144
DrugCentral1770
KEGGcpd:C08179
dr:D00979
ZINC118912449
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1PainFAERS: 78
Canada Vigilance: 5
1772484
17101836
CTD
OFFSIDES
Canada Vigilance
US FAERS
2HeadacheFAERS: 75
Canada Vigilance: 5
Canada Vigilance
US FAERS
3AnxietyFAERS: 58
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
4Incorrect route of drug administrationFAERS: 50OFFSIDES
US FAERS
5NauseaFAERS: 49
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
6Drug ineffectiveFAERS: 43
Canada Vigilance: 5
Canada Vigilance
US FAERS
7ArachnoiditisFAERS: 37
Canada Vigilance: 1
1257435
1772484
4740461
CTD
OFFSIDES
Canada Vigilance
US FAERS
8MalaiseFAERS: 35
Canada Vigilance: 4
Canada Vigilance
US FAERS
9HypersensitivityFAERS: 29
Canada Vigilance: 4
Canada Vigilance
US FAERS
10Product contaminationFAERS: 29US FAERS
11Injection site painFAERS: 28
Canada Vigilance: 4
Canada Vigilance
US FAERS
12FatigueFAERS: 27
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
13DizzinessFAERS: 26
Canada Vigilance: 3
Canada Vigilance
US FAERS
14Injection site abscessFAERS: 26US FAERS
15Back PainFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
16Feeling abnormalFAERS: 24OFFSIDES
US FAERS
17ArthralgiaFAERS: 23
Canada Vigilance: 3
Canada Vigilance
US FAERS
18MeningitisFAERS: 234740461CTD
US FAERS
19Product quality issueFAERS: 23US FAERS
20Product use issueFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
21PruritusFAERS: 23
Canada Vigilance: 4
Canada Vigilance
US FAERS
22UrticariaFAERS: 23
Canada Vigilance: 3
Canada Vigilance
US FAERS
23Musculoskeletal stiffnessFAERS: 22OFFSIDES
US FAERS
24InfectionFAERS: 19
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
25VomitingFAERS: 19
Canada Vigilance: 3
Canada Vigilance
US FAERS
26AbasiaFAERS: 18OFFSIDES
US FAERS
27AstheniaFAERS: 18OFFSIDES
US FAERS
28Burning sensationFAERS: 18
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
29ErythemaFAERS: 16
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
30Medication ErrorFAERS: 16
Canada Vigilance: 12
Canada Vigilance
US FAERS
31Injection site infectionFAERS: 15OFFSIDES
US FAERS
32Wrong drug administeredFAERS: 15OFFSIDES
US FAERS
33Atrial FibrillationFAERS: 14US FAERS
34Neck PainFAERS: 14US FAERS
35Weight decreasedFAERS: 14US FAERS
36Anaphylactic shockFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
37Product use in unapproved indicationFAERS: 13US FAERS
38Joint swellingFAERS: 12US FAERS
39TremorFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
40Urinary IncontinenceFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
41Blood glucose increasedFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
42Chest PainFAERS: 11OFFSIDES
US FAERS
43Drug administration errorFAERS: 11OFFSIDES
US FAERS
44FlushingFAERS: 11
Canada Vigilance: 3
Canada Vigilance
US FAERS
45AbscessFAERS: 10OFFSIDES
US FAERS
46Injection Site ReactionFAERS: 10
Canada Vigilance: 5
Canada Vigilance
US FAERS
47Injection site necrosisFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
48NeuralgiaFAERS: 10US FAERS
49No adverse eventFAERS: 10US FAERS
50OsteomyelitisFAERS: 10OFFSIDES
US FAERS
51Post procedural complicationFAERS: 10OFFSIDES
US FAERS
52Chest discomfortFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
53SwellingFAERS: 9US FAERS
54AlopeciaFAERS: 8
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
55Cerebrovascular accidentFAERS: 8US FAERS
56DiscomfortFAERS: 8US FAERS
57FormicationFAERS: 8
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
58Injection site erythemaFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
59Memory impairmentFAERS: 8US FAERS
60Nerve injuryFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
61PalpitationsFAERS: 8US FAERS
62Abdominal PainFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
63ChillsFAERS: 7
Canada Vigilance: 1
578589CTD
Canada Vigilance
US FAERS
64Drug dispensing errorFAERS: 7OFFSIDES
US FAERS
65MyalgiaFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
66Peripheral swellingFAERS: 7US FAERS
67Poor quality drug administeredFAERS: 7US FAERS
68Product contamination microbialFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
69SepsisFAERS: 7US FAERS
70TinnitusFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
71Activities of daily living impairedFAERS: 6OFFSIDES
US FAERS
72AmnesiaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
73BradycardiaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
74Cold sweatFAERS: 6US FAERS
75General physical health deteriorationFAERS: 6OFFSIDES
US FAERS
76Impaired work abilityFAERS: 6OFFSIDES
US FAERS
77Limb discomfortFAERS: 6US FAERS
78Lip swellingFAERS: 6US FAERS
79Myocardial InfarctionFAERS: 6US FAERS
80SyncopeFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
81ThrombosisFAERS: 6US FAERS
82VertigoFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
83Angina PectorisFAERS: 5US FAERS
84Bowel movement irregularityFAERS: 5US FAERS
85Cardiac ArrestFAERS: 5US FAERS
86Conjunctival ulcerFAERS: 5US FAERS
87Eye painFAERS: 5
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
88HepatitisFAERS: 5OFFSIDES
US FAERS
89Impaired driving abilityFAERS: 5US FAERS
90Injection site bruisingFAERS: 5US FAERS
91Injection site inflammationFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
92LethargyFAERS: 5US FAERS
93Musculoskeletal PainFAERS: 5OFFSIDES
US FAERS
94Psoas AbscessFAERS: 5US FAERS
95Pulmonary EmbolismFAERS: 5US FAERS
96Rash erythematousFAERS: 5US FAERS
97Wrong technique in drug usage processFAERS: 5US FAERS
98Antinuclear antibody increasedFAERS: 4OFFSIDES
US FAERS
99ArthritisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
100ArthropathyFAERS: 4OFFSIDES
US FAERS
101CellulitisFAERS: 4OFFSIDES
US FAERS
102Completed SuicideFAERS: 4US FAERS
103ConstipationFAERS: 4US FAERS
104DysuriaFAERS: 4OFFSIDES
US FAERS
105EczemaFAERS: 4OFFSIDES
US FAERS
106GoutFAERS: 4US FAERS
107LipoatrophyFAERS: 4US FAERS
108MonoplegiaFAERS: 4OFFSIDES
US FAERS
109Ocular discomfortFAERS: 4US FAERS
110PhotophobiaFAERS: 4US FAERS
111Product lot number issueFAERS: 4US FAERS
112Rheumatoid ArthritisFAERS: 4US FAERS
113Skin UlcerFAERS: 4US FAERS
114SomnolenceFAERS: 4US FAERS
115Wrong technique in product usage processFAERS: 4US FAERS
116AgitationFAERS: 3US FAERS
117Bladder dysfunctionFAERS: 3US FAERS
118Bone painFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
119BronchitisFAERS: 3OFFSIDES
US FAERS
120BronchospasmFAERS: 3US FAERS
121CataractFAERS: 3OFFSIDES
US FAERS
122Circumstance or information capable of leading to medication errorFAERS: 3OFFSIDES
US FAERS
123CryingFAERS: 3US FAERS
124Diabetes MellitusFAERS: 3US FAERS
125DysarthriaFAERS: 3US FAERS
126DysgeusiaFAERS: 3US FAERS
127Expired product administeredFAERS: 3US FAERS
128Feeling jitteryFAERS: 3US FAERS
129HypotensionFAERS: 3US FAERS
130Iatrogenic injuryFAERS: 3OFFSIDES
US FAERS
131Increased steroid activityFAERS: 3US FAERS
132InflammationFAERS: 3US FAERS
133Injection site atrophyFAERS: 3
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
134Injection site extravasationFAERS: 3US FAERS
135Liquid product physical issueFAERS: 3US FAERS
136Macular degenerationFAERS: 3US FAERS
137MyopathyFAERS: 3US FAERS
138NecrosisFAERS: 3US FAERS
139NervousnessFAERS: 3US FAERS
140OsteopeniaFAERS: 3OFFSIDES
US FAERS
141ParanoiaFAERS: 3OFFSIDES
US FAERS
142PneumoniaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
143Product identification number issueFAERS: 3US FAERS
144PurpuraFAERS: 3US FAERS
145RestlessnessFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
146ShockFAERS: 3US FAERS
147Skin texture abnormalFAERS: 3US FAERS
148SneezingFAERS: 3US FAERS
149Soft Tissue InfectionFAERS: 3US FAERS
150TachycardiaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
151Tooth ExtractionFAERS: 3OFFSIDES
US FAERS
152Visual ImpairmentFAERS: 3
Canada Vigilance: 3
Canada Vigilance
US FAERS
153Visual disturbanceFAERS: 3OFFSIDES
US FAERS
154Vulvovaginal painFAERS: 3OFFSIDES
US FAERS
155Walking aid userFAERS: 3OFFSIDES
US FAERS
156White blood cell count decreasedFAERS: 3US FAERS
157jaundiceFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
158Abdominal discomfortFAERS: 2
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
159Acute psychosisFAERS: 2US FAERS
160Adverse eventFAERS: 2US FAERS
161AnuriaFAERS: 2US FAERS
162AsthmaFAERS: 2US FAERS
163Autoimmune hepatitisFAERS: 2OFFSIDES
US FAERS
164BlindnessFAERS: 2
Canada Vigilance: 1
758896
4422330
10654762
CTD
Canada Vigilance
US FAERS
165Blood creatinine abnormalFAERS: 2US FAERS
166Blood pressure immeasurableFAERS: 2OFFSIDES
US FAERS
167Cartilage injuryFAERS: 2US FAERS
168Cauda Equina SyndromeFAERS: 2US FAERS
169Cerebral InfarctionFAERS: 2US FAERS
170Cerebral ThrombosisFAERS: 2OFFSIDES
US FAERS
171DeliriumFAERS: 2US FAERS
172Drug DependenceFAERS: 2US FAERS
173Drug effect incompleteFAERS: 2US FAERS
174DyspepsiaFAERS: 2US FAERS
175EcchymosisFAERS: 2US FAERS
176Erectile dysfunctionFAERS: 21772484CTD
US FAERS
177ExophthalmosFAERS: 2US FAERS
178Hepatic necrosisFAERS: 2US FAERS
179HepatotoxicityFAERS: 2US FAERS
180Histiocytosis haematophagicFAERS: 2OFFSIDES
US FAERS
181Hormone level abnormalFAERS: 2OFFSIDES
US FAERS
182Human herpesvirus 8 infectionFAERS: 2OFFSIDES
US FAERS
183HydrocephalusFAERS: 2OFFSIDES
US FAERS
184HyperthyroidismFAERS: 2US FAERS
185HypophagiaFAERS: 2OFFSIDES
US FAERS
186Incorrect dose administeredFAERS: 2US FAERS
187Incorrect route of product administrationFAERS: 2US FAERS
188Injection site irritationFAERS: 2OFFSIDES
US FAERS
189Joint InstabilityFAERS: 2US FAERS
190LentigoFAERS: 2US FAERS
191LymphangitisFAERS: 2US FAERS
192Meniscus injuryFAERS: 2US FAERS
193Mental status changesFAERS: 2OFFSIDES
US FAERS
194Middle insomniaFAERS: 2US FAERS
195Muscle FatigueFAERS: 2US FAERS
196Muscle RigidityFAERS: 2US FAERS
197Muscle tightnessFAERS: 2OFFSIDES
US FAERS
198Nerve root injuryFAERS: 2OFFSIDES
US FAERS
199Night sweatsFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
200Ocular sarcoidosisFAERS: 2US FAERS
201OnychomycosisFAERS: 2US FAERS
202Oropharyngeal painFAERS: 2
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
203OsteoporosisFAERS: 2OFFSIDES
US FAERS
204OverdoseFAERS: 2US FAERS
205PallorFAERS: 2US FAERS
206Pharmaceutical product complaintFAERS: 2US FAERS
207QuadriplegiaFAERS: 2US FAERS
208RadiculopathyFAERS: 29794061CTD
US FAERS
209Reaction to preservativesFAERS: 2US FAERS
210Retinal DetachmentFAERS: 2US FAERS
211SciaticaFAERS: 26071628CTD
US FAERS
212Septic arthritis staphylococcalFAERS: 2US FAERS
213Skin PapillomaFAERS: 2US FAERS
214Skin irritationFAERS: 2US FAERS
215StomatitisFAERS: 2US FAERS
216Subcutaneous AbscessFAERS: 2US FAERS
217Suicide attemptFAERS: 2US FAERS
218Therapy non-responderFAERS: 2US FAERS
219Transmission of an infectious agent via productFAERS: 2US FAERS
220Unevaluable eventFAERS: 2OFFSIDES
US FAERS
221Urethral intrinsic sphincter deficiencyFAERS: 2US FAERS
222Urinary RetentionFAERS: 2US FAERS
223VasospasmFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
224Vulvovaginal discomfortFAERS: 2OFFSIDES
US FAERS
225XerophthalmiaFAERS: 2US FAERS
226nervous system disorderFAERS: 2US FAERS
227Accidental exposure to productFAERS: 1US FAERS
228Accidental exposureFAERS: 1US FAERS
229Acute Lung InjuryFAERS: 1US FAERS
230Acute myocardial infarctionFAERS: 1OFFSIDES
US FAERS
231Acute respiratory failureFAERS: 1US FAERS
232Anal discomfortFAERS: 1US FAERS
233AngerFAERS: 1US FAERS
234AngioedemaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
235AnorexiaFAERS: 1US FAERS
236Aortic AneurysmFAERS: 1US FAERS
237AphasiaFAERS: 1US FAERS
238AphoniaFAERS: 1US FAERS
239Apparent deathFAERS: 1US FAERS
240Application site painFAERS: 1US FAERS
241Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
242Aspergillus test positiveFAERS: 1US FAERS
243AtaxiaFAERS: 1US FAERS
244Auricular swellingFAERS: 1US FAERS
245Autoimmune thyroiditisFAERS: 1US FAERS
246B-lymphocyte count decreasedFAERS: 1US FAERS
247Bacillus infectionFAERS: 1US FAERS
248Back disorderFAERS: 1US FAERS
249BedriddenFAERS: 1US FAERS
250Biopsy liver abnormalFAERS: 1US FAERS
251Bipolar DisorderFAERS: 1US FAERS
252Blood cholesterol increasedFAERS: 1US FAERS
253Blood glucose decreasedFAERS: 1OFFSIDES
US FAERS
254Blood immunoglobulin G decreasedFAERS: 1US FAERS
255Blood iron decreasedFAERS: 1US FAERS
256Blood pressure fluctuationFAERS: 1US FAERS
257Blood urine presentFAERS: 1US FAERS
258Body surface area decreasedFAERS: 1US FAERS
259Bone density decreasedFAERS: 1US FAERS
260Bone erosionFAERS: 1US FAERS
261Brain DeathFAERS: 1OFFSIDES
US FAERS
262CD4 Lymphocytes DecreasedFAERS: 1US FAERS
263Cardiac stress test abnormalFAERS: 1US FAERS
264Carpal Tunnel SyndromeFAERS: 1US FAERS
265Cartilage atrophyFAERS: 1US FAERS
266Cerebellar AtaxiaFAERS: 1US FAERS
267Cerebellar artery thrombosisFAERS: 1US FAERS
268Cerebellar infarctionFAERS: 1OFFSIDES
US FAERS
269CholelithiasisFAERS: 1US FAERS
270Chronic Fatigue SyndromeFAERS: 1US FAERS
271Chronic sinusitisFAERS: 1US FAERS
272Critical illness myopathyFAERS: 1US FAERS
273CystitisFAERS: 1US FAERS
274DeformityFAERS: 1US FAERS
275DehydrationFAERS: 1US FAERS
276Depressed moodFAERS: 1US FAERS
277Device computer issueFAERS: 1US FAERS
278Device occlusionFAERS: 1US FAERS
279Device related infectionFAERS: 1OFFSIDES
US FAERS
280Device use errorFAERS: 1US FAERS
281Diabetic KetoacidosisFAERS: 1US FAERS
282DiplopiaFAERS: 1OFFSIDES
US FAERS
283DisabilityFAERS: 1US FAERS
284DisorientationFAERS: 1US FAERS
285DiverticulitisFAERS: 1OFFSIDES
US FAERS
286Documented hypersensitivity to administered productFAERS: 1US FAERS
287Drug administered at inappropriate siteFAERS: 1US FAERS
288Drug clearance decreasedFAERS: 1US FAERS
289Drug dose omissionFAERS: 1US FAERS
290Drug ineffective for unapproved indicationFAERS: 1US FAERS
291Drug label confusionFAERS: 1US FAERS
292Drug toxicityFAERS: 1US FAERS
293Dry skinFAERS: 1OFFSIDES
US FAERS
294Duodenal UlcerFAERS: 1OFFSIDES
US FAERS
295DysgraphiaFAERS: 1US FAERS
296Ear discomfortFAERS: 1OFFSIDES
US FAERS
297EmbolismFAERS: 1758896
5507712
CTD
OFFSIDES
US FAERS
298Emotional disorderFAERS: 1OFFSIDES
US FAERS
299Emotional distressFAERS: 1OFFSIDES
US FAERS
300EncephalitisFAERS: 1OFFSIDES
US FAERS
301EndocarditisFAERS: 1US FAERS
302Epidural lipomatosisFAERS: 1OFFSIDES
US FAERS
303ErythromelalgiaFAERS: 1US FAERS
304Euphoric moodFAERS: 1US FAERS
305ExcoriationFAERS: 1US FAERS
306Eye irritationFAERS: 1US FAERS
307Facial PainFAERS: 1US FAERS
308Fascial ruptureFAERS: 1US FAERS
309Feeling ColdFAERS: 1US FAERS
310Feeling of body temperature changeFAERS: 1US FAERS
311Female Orgasmic DisorderFAERS: 1US FAERS
312FibromyalgiaFAERS: 1OFFSIDES
US FAERS
313FibrosisFAERS: 1US FAERS
314FrustrationFAERS: 1US FAERS
315Gait inabilityFAERS: 1US FAERS
316Gallbladder painFAERS: 1US FAERS
317Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
318GastritisFAERS: 1US FAERS
319Head discomfortFAERS: 1US FAERS
320HistoplasmosisFAERS: 1OFFSIDES
US FAERS
321Humoral immune defectFAERS: 1US FAERS
322HungerFAERS: 1US FAERS
323HypersomniaFAERS: 1US FAERS
324Hypertensive crisisFAERS: 1US FAERS
325Hypertrophic CardiomyopathyFAERS: 1OFFSIDES
US FAERS
326HypothyroidismFAERS: 1US FAERS
327HysterectomyFAERS: 1US FAERS
328Idiosyncratic drug reactionFAERS: 1US FAERS
329IleusFAERS: 1US FAERS
330ImmunosuppressionFAERS: 1US FAERS
331Impaired self-careFAERS: 1US FAERS
332Inappropriate schedule of drug administrationFAERS: 1US FAERS
333IncoherentFAERS: 1US FAERS
334Incorrect dose administered by deviceFAERS: 1US FAERS
335Injection site cellulitisFAERS: 1OFFSIDES
US FAERS
336Injection site dischargeFAERS: 1US FAERS
337Injection site discomfortFAERS: 1US FAERS
338Injection site massFAERS: 1US FAERS
339Injection site vesiclesFAERS: 1US FAERS
340Injection site warmthFAERS: 1US FAERS
341InjectionFAERS: 1US FAERS
342Injury associated with deviceFAERS: 1US FAERS
343Intentional drug misuseFAERS: 1US FAERS
344Intentional product use issueFAERS: 1US FAERS
345Intercepted drug dispensing errorFAERS: 1US FAERS
346Intervertebral Disc DegenerationFAERS: 1OFFSIDES
US FAERS
347Intestinal ObstructionFAERS: 1US FAERS
348Joint injuryFAERS: 1US FAERS
349Lacrimation decreasedFAERS: 1US FAERS
350Lipase increasedFAERS: 1US FAERS
351Lipodystrophy acquiredFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
352LipomaFAERS: 1US FAERS
353Meningeal disorderFAERS: 1US FAERS
354Mental impairmentFAERS: 1US FAERS
355Migraine with AuraFAERS: 1US FAERS
356Mood swingsFAERS: 1US FAERS
357Morbid thoughtsFAERS: 1US FAERS
358Multiple Chemical SensitivityFAERS: 1US FAERS
359Multiple SclerosisFAERS: 1OFFSIDES
US FAERS
360Muscle tone disorderFAERS: 1US FAERS
361Musculoskeletal discomfortFAERS: 1OFFSIDES
US FAERS
362MyoclonusFAERS: 1US FAERS
363Negative thoughtsFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
364Nephrotic SyndromeFAERS: 1US FAERS
365NeuritisFAERS: 1US FAERS
366NeuropathyFAERS: 1US FAERS
367Nipple inflammationFAERS: 1US FAERS
368NoduleFAERS: 1OFFSIDES
US FAERS
369Nonspecific reactionFAERS: 1US FAERS
370OnychoclasisFAERS: 1US FAERS
371Optic AtrophyFAERS: 1US FAERS
372Optic NeuritisFAERS: 1US FAERS
373Oral dischargeFAERS: 1OFFSIDES
US FAERS
374Oral pruritusFAERS: 1US FAERS
375OsteosclerosisFAERS: 1US FAERS
376Pancreatic carcinomaFAERS: 1US FAERS
377PancreatitisFAERS: 1US FAERS
378Panic DisorderFAERS: 1US FAERS
379ParaplegiaFAERS: 1OFFSIDES
US FAERS
380Penile swellingFAERS: 1US FAERS
381PericarditisFAERS: 1OFFSIDES
US FAERS
382Perineal painFAERS: 1US FAERS
383Personality ChangeFAERS: 1OFFSIDES
US FAERS
384Pharyngolaryngeal PainFAERS: 1US FAERS
385PhonophobiaFAERS: 1US FAERS
386PoisoningFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
387Poor peripheral circulationFAERS: 1OFFSIDES
US FAERS
388Post-Traumatic Stress DisorderFAERS: 1US FAERS
389Post-traumatic painFAERS: 1US FAERS
390Postoperative infectionFAERS: 1OFFSIDES
US FAERS
391Postoperative wound complicationFAERS: 1US FAERS
392Prescribed overdoseFAERS: 1US FAERS
393Product administered at inappropriate siteFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
394Product administration errorFAERS: 1US FAERS
395Product formulation issueFAERS: 1US FAERS
396Product label issueFAERS: 1US FAERS
397PyopneumothoraxFAERS: 1US FAERS
398Quality of life decreasedFAERS: 1OFFSIDES
US FAERS
399Reaction to drug excipientsFAERS: 1US FAERS
400Recalled product administeredFAERS: 1US FAERS
401Respiratory FailureFAERS: 1OFFSIDES
US FAERS
402Respiratory arrestFAERS: 1US FAERS
403Respiratory distressFAERS: 1US FAERS
404Restless Legs SyndromeFAERS: 1US FAERS
405Retinal DegenerationFAERS: 1US FAERS
406Retinal toxicityFAERS: 1US FAERS
407RhinitisFAERS: 1758896CTD
OFFSIDES
US FAERS
408Rotator cuff syndromeFAERS: 1US FAERS
409Scleroderma renal crisisFAERS: 1US FAERS
410ScreamingFAERS: 1US FAERS
411Sensitive skinFAERS: 1US FAERS
412Septic ShockFAERS: 1US FAERS
413Sexual DysfunctionFAERS: 1US FAERS
414Similar reaction on previous exposure to drugFAERS: 1US FAERS
415Sinus TachycardiaFAERS: 1US FAERS
416Skin IndurationFAERS: 1US FAERS
417Skin lesionFAERS: 1OFFSIDES
US FAERS
418Skin reactionFAERS: 1US FAERS
419Soft tissue atrophyFAERS: 1US FAERS
420Spinal column stenosisFAERS: 1OFFSIDES
US FAERS
421Staphylococcal abscessFAERS: 1US FAERS
422StressFAERS: 1US FAERS
423StrongyloidiasisFAERS: 1US FAERS
424Sudden deathFAERS: 1US FAERS
425SunburnFAERS: 1US FAERS
426Surgical failureFAERS: 1US FAERS
427Suspected counterfeit productFAERS: 1US FAERS
428SynovitisFAERS: 1US FAERS
429Syringe issueFAERS: 1US FAERS
430Temperature intoleranceFAERS: 1US FAERS
431Tendon necrosisFAERS: 1US FAERS
432TenosynovitisFAERS: 1US FAERS
433TetanyFAERS: 1US FAERS
434ThirstFAERS: 1US FAERS
435Throat irritationFAERS: 1US FAERS
436ThrombocytopeniaFAERS: 1US FAERS
437Tooth AvulsionFAERS: 1US FAERS
438TorticollisFAERS: 1US FAERS
439Toxicity to various agentsFAERS: 1US FAERS
440Tympanic Membrane PerforationFAERS: 1US FAERS
441UlcerFAERS: 1OFFSIDES
US FAERS
442UrethritisFAERS: 1US FAERS
443Urine ketone body presentFAERS: 1OFFSIDES
US FAERS
444VIIth nerve paralysisFAERS: 1OFFSIDES
US FAERS
445Varicella Zoster Virus InfectionFAERS: 1US FAERS
446VasculitisFAERS: 1US FAERS
447Vessel perforationFAERS: 1US FAERS
448WheezingFAERS: 1US FAERS
449Wound ComplicationFAERS: 1US FAERS
450fibromaFAERS: 1US FAERS
451Abscess soft tissueOFFSIDES
452AbuseOFFSIDES
453Acid refluxOFFSIDES
454AcneOFFSIDES
455Acute bronchitisOFFSIDES
456AdenocarcinomaOFFSIDES
457AdenomaOFFSIDES
458AgeusiaOFFSIDES
459AgraphiaOFFSIDES
460Alcohol abuseOFFSIDES
461Alcohol consumptionOFFSIDES
462AmenorrheaOFFSIDES
463Ammonia increasedOFFSIDES
464AmputationOFFSIDES
465AnalgesiaOFFSIDES
466Anaphylactoid ReactionCanada Vigilance: 1Canada Vigilance
467Angle Closure GlaucomaOFFSIDES
468AnhedoniaOFFSIDES
469AnhidrosisOFFSIDES
470Ankle FractureOFFSIDES
471Antimicrobial susceptibility test resistantOFFSIDES
472Aortic bypassOFFSIDES
473ApathyOFFSIDES
474ArteriosclerosisOFFSIDES
475ArthrodesisOFFSIDES
476ArthroscopyOFFSIDES
477AspergillosisOFFSIDES
478AsthenopiaOFFSIDES
479AstigmatismOFFSIDES
480AtelectasisOFFSIDES
481Atrial tachycardiaOFFSIDES
482Atrioventricular BlockOFFSIDES
483Atrophic vulvovaginitisOFFSIDES
484Axonal neuropathyOFFSIDES
485Bacterial disease carrierOFFSIDES
486Basal cell carcinomaOFFSIDES
487Benign neoplasm of thyroid glandOFFSIDES
488Biopsy bone marrow abnormalOFFSIDES
489Biopsy breast abnormalOFFSIDES
490BlepharoptosisOFFSIDES
491Blood GlucoseOFFSIDES
492Blood bilirubin unconjugated increasedOFFSIDES
493Blood cholesterolOFFSIDES
494Blood cortisol decreasedOFFSIDES
495Blood cortisol increasedOFFSIDES
496Blood fibrinogenOFFSIDES
497Blood lactate dehydrogenase increasedOFFSIDES
498Blood osmolarity decreasedOFFSIDES
499Blood parathyroid hormone increasedOFFSIDES
500Blood prolactin increasedOFFSIDES
501Blood uric acidOFFSIDES
502Blurred visionOFFSIDES
503Bone abscessOFFSIDES
504Bone marrow necrosisOFFSIDES
505Breast CystOFFSIDES
506Breast MicrocalcificationOFFSIDES
507Breast cancer stage IIOFFSIDES
508Breast cosmetic surgeryOFFSIDES
509Breast hyperplasiaOFFSIDES
510Breast necrosisOFFSIDES
511BronchiectasisOFFSIDES
512Bronchopleural FistulaOFFSIDES
513Bronchoscopy abnormalOFFSIDES
514BursitisCanada Vigilance: 1Canada Vigilance
OFFSIDES
515Candida sepsisOFFSIDES
516Cardiac TamponadeOFFSIDES
517Cardioactive drug level increasedOFFSIDES
518Cataract operationOFFSIDES
519CausalgiaOFFSIDES
520Cerebral arteritisOFFSIDES
521Cerebral atrophyOFFSIDES
522Choking sensationOFFSIDES
523CholecystitisOFFSIDES
524ChondromalaciaOFFSIDES
525Choroid Diseases12055481CTD
526Chronic Obstructive Airway DiseaseOFFSIDES
527Chronic left ventricular failureOFFSIDES
528Cicatrix10654762CTD
529Clostridium difficile toxin test positiveOFFSIDES
530ClubbingOFFSIDES
531Colon adenomaOFFSIDES
532Compression fractureOFFSIDES
533Compulsive shoppingOFFSIDES
534ConfabulationOFFSIDES
535Confusion578589CTD
536Congenital pyelocaliectasisOFFSIDES
537Conjunctival depositOFFSIDES
538Contact DermatitisOFFSIDES
539Corneal dystrophyOFFSIDES
540Coronary angioplastyOFFSIDES
541Culture positiveOFFSIDES
542Cushing Syndrome11004305CTD
543Cyst aspirationOFFSIDES
544CystCanada Vigilance: 1Canada Vigilance
OFFSIDES
545Cytolytic hepatitisOFFSIDES
546Cytomegalovirus chorioretinitisOFFSIDES
547DeafnessOFFSIDES
548DebridementOFFSIDES
549DemyelinationOFFSIDES
550Dental cariesOFFSIDES
551Dental discomfortOFFSIDES
552Denture wearerOFFSIDES
553Depression suicidalOFFSIDES
554DiabetesOFFSIDES
555Diabetes mellitus inadequate controlOFFSIDES
556Diabetic NephropathyOFFSIDES
557DiarrheaOFFSIDES
558Disseminated Intravascular CoagulationOFFSIDES
559DiverticulosisOFFSIDES
560DiverticulumOFFSIDES
561Drug withdrawal headacheOFFSIDES
562DyspareuniaOFFSIDES
563Ear congestionOFFSIDES
564Early satietyOFFSIDES
565Economic problemOFFSIDES
566EmpyemaOFFSIDES
567Endodontic procedureOFFSIDES
568Endometrial disorderOFFSIDES
569Endometrial hypertrophyOFFSIDES
570Engraftment syndromeOFFSIDES
571EpicondylitisOFFSIDES
572Erythema marginatumOFFSIDES
573Eye laser surgeryOFFSIDES
574Eyelid margin crustingOFFSIDES
575Factor VIII DeficiencyOFFSIDES
576Failure to ThriveOFFSIDES
577Fasciitis, Plantar14525843CTD
578Fat necrosisOFFSIDES
579Febrile bone marrow aplasiaOFFSIDES
580Fever578589CTD
581Fibroadenoma of breastOFFSIDES
582FilariasisOFFSIDES
583Flank PainOFFSIDES
584FolliculitisOFFSIDES
585Food PoisoningOFFSIDES
586Foot Dermatoses3155925CTD
587Gastric BypassOFFSIDES
588Gastric ulcerOFFSIDES
589Gastrointestinal infectionOFFSIDES
590Gastrointestinal motility disorderOFFSIDES
591Gastrointestinal toxicityOFFSIDES
592GlobulinuriaOFFSIDES
593GlomerulonephritisOFFSIDES
594Graft infectionOFFSIDES
595Granuloma13129887CTD
OFFSIDES
596Hallucinations, mixedOFFSIDES
597Hand Dermatoses3155925CTD
598Haptoglobin DecreasedOFFSIDES
599Heart-lung transplant rejectionOFFSIDES
600Hemangioma12055481CTD
601HemiparesisOFFSIDES
602HiccoughOFFSIDES
603High density lipoprotein increasedOFFSIDES
604Hilar lymphadenopathyOFFSIDES
605HydronephrosisOFFSIDES
606HydropneumothoraxOFFSIDES
607Hyperosmolar stateOFFSIDES
608HyperparathyroidismOFFSIDES
609Hypertensive heart diseaseOFFSIDES
610HypertrichosisCanada Vigilance: 1Canada Vigilance
OFFSIDES
611HypogeusiaOFFSIDES
612Hysterosalpingo-oophorectomyOFFSIDES
613Immunosuppressant drug level decreasedOFFSIDES
614IncontinenceOFFSIDES
615IndurationOFFSIDES
616Infected cystOFFSIDES
617Infection in an immunocompromised hostOFFSIDES
618Infusion site mobility decreasedOFFSIDES
619IntertrigoOFFSIDES
620Intervertebral disc compressionOFFSIDES
621Intervertebral disc disorderOFFSIDES
622Intracranial AneurysmOFFSIDES
623Intracranial HypotensionOFFSIDES
624IridectomyOFFSIDES
625IridocyclitisOFFSIDES
626Joint Range of Motion DecreasedOFFSIDES
627Joint sprainOFFSIDES
628Large intestine perforationOFFSIDES
629Left Ventricular HypertrophyOFFSIDES
630Left atrial dilatationOFFSIDES
631LeukocytosisCanada Vigilance: 1Canada Vigilance
632Leukopenia neonatalOFFSIDES
633Limb injuryOFFSIDES
634Limb operationOFFSIDES
635Lipomatosis1771466
10414580
CTD
636Low Back Pain10414580CTD
637Lumbar radiculopathyOFFSIDES
638Lung hyperinflationOFFSIDES
639Lung squamous cell carcinoma stage IIOFFSIDES
640Lymph node cancer metastaticOFFSIDES
641LymphedemaOFFSIDES
642LymphocytosisOFFSIDES
643MacrocytosisOFFSIDES
644MastectomyOFFSIDES
645Mastication disorderOFFSIDES
646MastoiditisOFFSIDES
647Mechanical ventilationOFFSIDES
648MeningiomaOFFSIDES
649Meningism1862897CTD
650Meniscus removalOFFSIDES
651MetaplasiaOFFSIDES
652Modified radical mastectomyOFFSIDES
653Mole excisionOFFSIDES
654MonocytosisOFFSIDES
655Multiple MyelomaOFFSIDES
656Muscle WeaknessOFFSIDES
657Muscle flap operationOFFSIDES
658Musculoskeletal chest painOFFSIDES
659MyelitisOFFSIDES
660MyelocytosisOFFSIDES
661MyelodysplasiaOFFSIDES
662NephrolithiasisOFFSIDES
663NeuromaOFFSIDES
664Neutrophil count abnormalOFFSIDES
665Non-cardiac chest painOFFSIDES
666Non-small cell lung cancer recurrentOFFSIDES
667NystagmusOFFSIDES
668Open reduction of fractureOFFSIDES
669Open woundOFFSIDES
670OsteolysisOFFSIDES
671OsteoradionecrosisOFFSIDES
672PROTHROMBIN TIMEOFFSIDES
673Paranasal sinus hypersecretionOFFSIDES
674ParathyroidectomyOFFSIDES
675Paresthesia3155925CTD
676Pelvic fluid collectionOFFSIDES
677Peptic Ulcer PerforationOFFSIDES
678Peritoneal DialysisOFFSIDES
679PeritonitisOFFSIDES
680Pharyngeal swellingCanada Vigilance: 1Canada Vigilance
681PhlebitisCanada Vigilance: 1Canada Vigilance
OFFSIDES
682PlasmacytomaOFFSIDES
683Pneumocystis jiroveci pneumoniaOFFSIDES
684PneumothoraxCanada Vigilance: 1Canada Vigilance
OFFSIDES
685Polycystic Kidney Diseases3945365
8724899
CTD
686PolymyositisOFFSIDES
687PolyneuropathyOFFSIDES
688PolyuriaOFFSIDES
689Poor quality sleepOFFSIDES
690Positron emission tomogram abnormalOFFSIDES
691Post procedural bile leakOFFSIDES
692Post procedural fistulaOFFSIDES
693Posterior CapsulotomyOFFSIDES
694Postmenopausal bleedingOFFSIDES
695Postoperative abscessOFFSIDES
696PresbyopiaOFFSIDES
697Productive CoughOFFSIDES
698Progesterone receptor assayOFFSIDES
699ProteinuriaCanada Vigilance: 1Canada Vigilance
700PsoriasisOFFSIDES
701Pulmonary HypertensionOFFSIDES
702Pulmonary InfarctionOFFSIDES
703Pulmonary thrombosisOFFSIDES
704PyelonephritisOFFSIDES
705Pyoderma GangrenosumOFFSIDES
706Radiation associated painOFFSIDES
707Radiation skin injuryOFFSIDES
708Radicular painOFFSIDES
709RalesOFFSIDES
710Rectal polypOFFSIDES
711Retinal Artery Occlusion733189
12055481
CTD
712Retinal Diseases10654762CTD
713Sclerosis13129887CTD
714Scotoma758896CTD
715Sensorimotor disorderOFFSIDES
716SeptoplastyOFFSIDES
717SequestrectomyOFFSIDES
718SeromaOFFSIDES
719Sinus bradycardiaOFFSIDES
720Sinus operationOFFSIDES
721SinusitisOFFSIDES
722Skin lacerationOFFSIDES
723Skin necrosisOFFSIDES
724Small Intestinal StenosisOFFSIDES
725Soft Tissue InjuriesOFFSIDES
726Spinal Cord Diseases1771466CTD
727Spinal Cord Injuries9794061CTD
728Spinal Stenosis10414580CTD
729SpondylolisthesisOFFSIDES
730Stem cell transplantOFFSIDES
731Sudden Cardiac DeathOFFSIDES
732Supraventricular tachycardiaOFFSIDES
733Synovial CystOFFSIDES
734T-Cell LymphomaOFFSIDES
735TendinitisOFFSIDES
736Therapeutic procedureOFFSIDES
737Therapeutic product effect incompleteCanada Vigilance: 3Canada Vigilance
738ThoracotomyOFFSIDES
739Thyroid gland scan abnormalOFFSIDES
740Tinea PedisOFFSIDES
741TineaOFFSIDES
742Tobacco userOFFSIDES
743Tooth LossOFFSIDES
744TracheobronchitisOFFSIDES
745Trigeminal Nerve DisorderOFFSIDES
746Tryptase increasedOFFSIDES
747Tuberculosis, Meningeal6071628CTD
748Ulnar NeuritisOFFSIDES
749Ultrasound scan abnormalOFFSIDES
750Uveitis, Posterior11004305CTD
751Vascular calcificationOFFSIDES
752VertebroplastyOFFSIDES
753Vision Disorders3964629CTD
754VitrectomyOFFSIDES
755Vitreous DetachmentOFFSIDES
756Vocal Cord ParalysisOFFSIDES
757Weight GainOFFSIDES
758Wheelchair userOFFSIDES
759Withdrawal of life supportOFFSIDES
760Wound dehiscenceOFFSIDES
761Wound infection pseudomonasOFFSIDES
762Wound infection staphylococcalOFFSIDES
763Wound necrosisOFFSIDES
764effusionOFFSIDES
765treatment failureOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.